Michael Ryan from Boston Scientific explained, "We consider ourselves a strategic investor. For us to invest in a company, three things need to be true: it needs to be an investment-grade asset with a great team and technology, it must be available at terms that provide the potential for financial return. https://www.lsieuropesummit.com/news/medtech-investments-what-are-medtechs-corporate-development-venture-leaders-pursuing-in-todays-climate